Y-mAbs is a late-stage clinical, global biopharmaceutical company specializing in developing antibody-based products to treat challenging pediatric cancers, and ultimately adult patients.

From prevention to treatment, we transform scientific innovation into healthcare solutions in Human Vaccines, Rare Diseases, Multiple Sclerosis & Neuroscience, Oncology, Immunology, Diabetes & Cardiovascular, Digital Technology, Drug Discovery & Biologics, and Consumer Healthcare.

Jubilant Radiopharma is an industry leading pharmaceutical company specializing in nuclear medicine focused on developing, manufacturing, commercializing and distributing high quality and sustainable diagnostic and therapeutic agents for the sole purpose of Improving Lives Through Nuclear Medicine on a global scale.

Bringing business insights, educational resources and best-in-class events to data protection, privacy and security professionals across the globe.